A Phase II Dose Response Study in Japan in Chronic Hepatitis B

Clinical trial NCT01022801 · COMPLETED

Trial details

NCT number: NCT01022801
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2003-08-01
Primary completion: 2005-03-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.